Related Experiment Video

Updated: Apr 30, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.3K

Growth inhibitory effects of large subunit ribosomal proteins in melanoma

Gregory R Kardos1, Mu-Shui Dai, Gavin P Robertson

  • 1Department of Pharmacology, The Pennsylvania State University College of Medicine, Hershey, PA, USA; The Melanoma Center, The Pennsylvania State University College of Medicine, Hershey, PA, USA; The Melanoma Therapeutics Program, The Pennsylvania State University College of Medicine, Hershey, PA, USA.

Pigment Cell & Melanoma Research
|May 9, 2014
PubMed

Insights

Targeting specific large subunit ribosomal proteins (RPLs) can inhibit melanoma growth. Category 2 RPLs, like RPL13, decrease cell viability and protein synthesis, impacting tumor development via the MDM2-p53 pathway.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Ribosome biogenesis is crucial for cancer cell proliferation by regulating protein synthesis.
  • Large subunit ribosomal proteins (RPLs) play a role in cancer, but their specific functions in melanoma require further investigation.

Purpose of the Study:

  • To dissect the involvement of RPLs in melanoma.
  • To categorize RPLs based on their impact on cell proliferation and therapeutic potential.
  • To elucidate the molecular mechanisms by which certain RPLs affect melanoma.

Main Methods:

  • Categorization of RPLs based on their effects on cell viability, p53 expression, and protein translation.
  • Utilizing siRNA-mediated targeting to investigate the role of RPL13 in melanoma.
  • Analyzing the interaction between RPL13, RPL5, RPL11, MDM2, and p53.

Main Results:

  • Two categories of RPLs were identified: those with negligible effects and those that decrease cell viability and inhibit protein synthesis.
  • RPL13 was identified as a category 2 RPL, where its targeting inhibited melanoma tumor development by reducing cellular proliferation.
  • Decreased RPL13 levels led to increased p53 stability via RPL5 and RPL11, inhibiting MDM2-mediated p53 degradation, resulting in p53-dependent cell cycle arrest and reduced protein translation.

Conclusions:

  • Targeting category 2 RPL proteins, such as RPL13, represents a potential therapeutic strategy for melanoma.
  • The MDM2-p53 pathway is a key mediator in the anti-melanoma effects of targeting specific RPLs.
  • Understanding RPL functions provides insights into novel therapeutic targets for melanoma treatment.
Keywords:
RP-MDM2-p53cell cyclemelanomap53protein synthesisribosomal proteins

More Related Videos

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research06:25

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research

Published on: March 29, 2024

1.9K
Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues08:06

Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues

Published on: July 8, 2020

5.1K

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
106
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.6K